These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9493146)

  • 1. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
    Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D
    Lupus; 1998; 7(1):29-36. PubMed ID: 9493146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
    El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
    Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A in the long-term management of systemic lupus erythematosus.
    Germano V; Picchianti Diamanti A; Ferlito C; Podestà E; Salemi S; Migliore A; D' Amelio R; Laganà B
    J Biol Regul Homeost Agents; 2011; 25(3):397-403. PubMed ID: 22023764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
    Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
    Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine treatment of lupus membranous nephropathy.
    Radhakrishnan J; Kunis CL; D'Agati V; Appel GB
    Clin Nephrol; 1994 Sep; 42(3):147-54. PubMed ID: 7994932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
    Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
    Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity.
    Tokuda M; Kurata N; Mizoguchi A; Inoh M; Seto K; Kinashi M; Takahara J
    Arthritis Rheum; 1994 Apr; 37(4):551-8. PubMed ID: 8147933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of systemic lupus erythematosus with cyclosporin A.
    Caccavo D; Laganà B; Mitterhofer AP; Ferri GM; Afeltra A; Amoroso A; Bonomo L
    Arthritis Rheum; 1997 Jan; 40(1):27-35. PubMed ID: 9008597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
    Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy.
    Suzuki K; Tanaka H; Tsugawa K; Ito E
    Tohoku J Exp Med; 2006 Apr; 208(4):355-9. PubMed ID: 16565599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.